EichorEICHOR
Location: Hawthorne Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Hawthorne

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Local Institution - 0356 · Bristol-Myers Squibb · NCT06561386A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
Phase 3 · Ep0156 259 · UCB Biopharma SRL · NCT04715646A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
Phase 3 · Boston Children's Health Physicians · Pfizer · NCT07573462Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
Phase 3 · Adaptive Research Inc. · Curium US LLC · NCT06235151Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Phase 3 · Advanced Investigative Medicine, Inc. · Pfizer · NCT05156398Study With Phage for CF Subjects With Pseudomonas Lung Infection
Phase 2 · New York Medical College · BiomX Ltd · NCT06998043Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years
Phase 1/Phase 2 · Sanofi · NCT07734649The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Phase 3 · New York Medical College - Hawthorne · Boehringer Ingelheim · NCT06872892MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Ha
Phase 3 · WMCHealth Advanced Physician Services · Pfizer · NCT06152575A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus
Phase 2/Phase 3 · WMCHealth Advanced Physician Services · Bristol-Myers Squibb · NCT07063745Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY A
Phase 3 · Boston Children's Health Physicians - Hawthorne- Site Number · Sanofi · NCT06191315A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With
Phase 3 · Research Site · AstraZeneca · NCT06023589A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Phase 2 · Westchester Medical Center · Amgen · NCT06570798Optimizing the Floreciendo Sexual and Reproductive Health Workshop for Latina Teens and Female Caregivers: A Pilot
NA · University of Illinois at Chicago · NCT06223165Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years
Phase 3 · Research Site · AstraZeneca · NCT06307665A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Phase 2/Phase 3 · BCHP · Biohaven Therapeutics Ltd. · NCT06132893MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Socal Surg Ctr · Stryker Instruments · NCT03072927Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Ch
Phase 3 · AbbVie · NCT05125302American Lung Association (ALA) Lung Health Cohort
Phase N/A · New York Medical College · Johns Hopkins University · NCT04543461Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initi
NA · Mt. Grant General Hospital · Timothy Mullett · NCT07682597A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Phase 3 · Novo Nordisk A/S · NCT07567001A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment
Phase 1 · Boston Children's Health Physicians · Jazz Pharmaceuticals · NCT07233239A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Phase 1 · New York Medical College/ Boston Children's Health Physician · Krystal Biotech, Inc. · NCT05504837
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.